Cineverse (CNVS) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
13 Aug, 2026Executive summary
Revenue increased 175% year-over-year to $30.6 million, driven by acquisitions of Giant Worldwide and IndiCue and strong technology growth.
Adjusted EBITDA improved by $2.6 million to $0.5 million, marking the second consecutive positive quarter, despite integration and acquisition-related costs.
Net loss attributable to common stockholders was $5.8 million ($0.28 per share), compared to $3.6 million ($0.21 per share) last year, reflecting higher operating and acquisition-related expenses.
Technology revenues now represent over 60% of consolidated total, becoming the largest and most recurring revenue source.
Operating cash flow improved by over $13 million year-over-year.
Financial highlights
Revenues reached $30.6 million, up from $11.1 million in the same quarter last year.
Advertising Technology contributed $15.9 million (52% of total revenue); streaming and digital revenue grew 7% to $9.7 million.
Direct operating margin declined to 35% from 57% prior quarter, mainly due to higher revenue share expenses.
SG&A expenses rose 30% to $11.6 million, driven by compensation, marketing, and integration costs.
Ended the quarter with $4.3 million in cash and $12.5 million revolver available.
Outlook and guidance
Reaffirmed fiscal year 2027 guidance: $115–$120 million in revenue and $10–$20 million in adjusted EBITDA.
Cost savings and synergy program targets $13 million annualized, with $8.3 million already executed; majority of savings expected in H2.
Anticipate strong second half driven by U.S. midterm elections, holiday season, and new theatrical releases.
Free cash flow expected to turn meaningfully positive and accelerate due to revenue synergies, cost saves, and lower CapEx.
Cash, cash equivalents, and available credit are believed sufficient to support operations for at least twelve months from the filing date.
Latest events from Cineverse
- Approval sought for major share issuance tied to acquisition and convertible notes, with dilution risk.CNVS
Proxy filing - Approval sought for major share issuance tied to acquisition and notes, with dilution and control impacts.CNVS
Proxy filing - Q4 revenue up 67% year-over-year; 2027 guidance reaffirmed with strong acquisition synergies.CNVS
Q4 2026 - Registering 21.8M shares for resale, with proceeds from warrants to fund growth and content.CNVS
Registration Filing - Revenue down 60% year-over-year; FY27 guidance boosted by accretive acquisitions.CNVS
Q3 2026 - Q2 revenue up 20% (ex-digital cinema); Terrifier 3 to drive major future profit gains.CNVS
Q2 2025 - Revenue fell 30% but margins, viewership, and future sales pipeline all improved.CNVS
Q1 2025 - Adjusted EBITDA rose to $4.4M on cost cuts, margin gains, and new channel growth.CNVS
Q4 2024 - Record revenue and net income, zero debt, and strong growth driven by Terrifier 3.CNVS
Q3 2025